|
1
|
Xiao Y, Zhou Q, Xu Y, Yuan SL and Liu QA:
Positive thyroid antibodies and risk of thyroid cancer: A
systematic review and meta-analysis. Mol Clin Oncol. 11:234–242.
2019.PubMed/NCBI
|
|
2
|
Xing M: Molecular pathogenesis and
mechanisms of thyroid cancer. Nat Rev Cancer. 13:184–199. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bonjoc KJ, Young H, Warner S, Gernon T,
Maghami E and Chaudhry A: Thyroid cancer diagnosis in the era of
precision imaging. J Thorac Dis. 12:5128–5139. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Reale C, Russo F, Credendino SC, Cuomo D,
De Vita G, Mallardo M, Pennino F, Porreca I, Triassi M, De Felice
M, et al: A toxicogenomic approach reveals a novel gene regulatory
network active in in vitro and in vivo models of thyroid
carcinogenesis. Int J Environ Res Public Health. 16:162019.
View Article : Google Scholar
|
|
5
|
Samimi H, Haghpanah V, Irani S, Arefian E,
Sohi AN, Fallah P and Soleimani M: Transcript-level regulation of
MALAT1-mediated cell cycle and apoptosis genes using dual
MEK/Aurora kinase inhibitor ‘BI-847325’ on anaplastic thyroid
carcinoma. Daru. 27:1–7. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ouyang F, Liu J, Xia M, Lin C, Wu X, Ye L,
Song L, Li J, Wang J, Guo P, et al: GINS2 is a novel prognostic
biomarker and promotes tumor progression in early-stage cervical
cancer. Oncol Rep. 37:2652–2662. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yan T, Liang W, Jiang E, Ye A, Wu Q and Xi
M: GINS2 regulates cell proliferation and apoptosis in human
epithelial ovarian cancer. Oncol Lett. 16:2591–2598.
2018.PubMed/NCBI
|
|
8
|
Peng L, Song Z, Chen D, Linghu R, Wang Y,
Zhang X, Kou X, Yang J and Jiao S: GINS2 regulates matrix
metallopeptidase 9 expression and cancer stem cell property in
human triple negative breast cancer. Biomed Pharmacother.
84:1568–1574. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ye Y, Song YN, He SF, Zhuang JH, Wang GY
and Xia W: GINS2 promotes cell proliferation and inhibits cell
apoptosis in thyroid cancer by regulating CITED2 and LOXL2. Cancer
Gene Ther. 26:103–113. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu C, Wang R and Zhang Y: GINS complex
subunit 2 (GINS2) plays a protective role in alcohol-induced brain
injury. Artif Cells Nanomed Biotechnol. 47:1–9. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng M, Zhou Y, Yang X, Tang J, Wei D,
Zhang Y, Jiang JL, Chen ZN and Zhu P: High GINS2 transcript level
predicts poor prognosis and correlates with high histological grade
and endocrine therapy resistance through mammary cancer stem cells
in breast cancer patients. Breast Cancer Res Treat. 148:423–436.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rantala JK, Edgren H, Lehtinen L, Wolf M,
Kleivi K, Vollan HK, Aaltola AR, Laasola P, Kilpinen S, Saviranta
P, et al: Integrative functional genomics analysis of sustained
polyploidy phenotypes in breast cancer cells identifies an
oncogenic profile for GINS2. Neoplasia. 12:877–888. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shen YL, Li HZ, Hu YW, Zheng L and Wang Q:
Loss of GINS2 inhibits cell proliferation and tumorigenesis in
human gliomas. CNS Neurosci Ther. 25:273–287. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao Y, Wang S, Liu B and Zhong L: Roles of
GINS2 in K562 human chronic myelogenous leukemia and NB4 acute
promyelocytic leukemia cells. Int J Mol Med. 31:1402–1410. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang X, Zhong L, Liu BZ, Gao YJ, Gao YM
and Hu XX: Effect of GINS2 on proliferation and apoptosis in
leukemic cell line. Int J Med Sci. 10:1795–1804. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
MacNeill SA: Structure and function of the
GINS complex, a key component of the eukaryotic replisome. Biochem
J. 425:489–500. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim EK and Choi EJ: Compromised MAPK
signaling in human diseases: An update. Arch Toxicol. 89:867–882.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun J and Nan G: The mitogen-activated
protein kinase (MAPK) signaling pathway as a discovery target in
stroke. J Mol Neurosci. 59:90–98. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Burotto M, Chiou VL, Lee JM and Kohn EC:
The MAPK pathway across different malignancies: A new perspective.
Cancer. 120:3446–3456. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gyurkó MD, Steták A, Sőti C and Csermely
P: Multitarget network strategies to influence memory and
forgetting: The Ras/MAPK pathway as a novel option. Mini Rev Med
Chem. 15:696–704. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cuadrado A and Nebreda AR: Mechanisms and
functions of p38 MAPK signalling. Biochem J. 429:403–417. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma Y, Zhao Q, Shao Y, Cao MZ, Zhao M and
Wang D: Melatonin inhibits the inflammation and apoptosis in rats
with diabetic retinopathy via MAPK pathway. Eur Rev Med Pharmacol
Sci. 23 (Suppl):1–8. 2019.PubMed/NCBI
|
|
23
|
Shang H, Cao Z, Zhao J, Guan J, Liu J,
Peng J, Chen Y, Joseph Sferra T, Sankararaman S and Lin J: Babao
Dan induces gastric cancer cell apoptosis via regulating MAPK and
NF-κB signaling pathways. J Int Med Res. 47:5106–5119. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tang G, Zeng Z, Sun W, Li S, You C, Tang
F, Peng S, Ma S, Luo Y, Xu J, et al: Small nucleolar RNA 71A
promotes lung cancer cell proliferation, migration and invasion via
MAPK/ERK pathway. J Cancer. 10:2261–2275. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yasui H, Kajiyama H, Tamauchi S, Suzuki S,
Peng Y, Yoshikawa N, Sugiyama M, Nakamura K and Kikkawa F: CCL2
secreted from cancer-associated mesothelial cells promotes
peritoneal metastasis of ovarian cancer cells through the P38-MAPK
pathway. Clin Exp Metastasis. 37:145–158. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jin C, Chen Z, Shi W and Lian Q:
Tropomodulin 3 promotes liver cancer progression by activating the
MAPK/ERK signaling pathway. Oncol Rep. 41:3060–3068.
2019.PubMed/NCBI
|
|
27
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim EK and Choi EJ: Pathological roles of
MAPK signaling pathways in human diseases. Biochim Biophys Acta.
1802:396–405. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lavoie H, Gagnon J and Therrien M: ERK
signalling: A master regulator of cell behaviour, life and fate.
Nat Rev Mol Cell Biol. 21:607–632. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Semba T, Sammons R, Wang X, Xie X, Dalby
KN and Ueno NT: JNK signaling in stem cell self-renewal and
differentiation. Int J Mol Sci. 21:212020. View Article : Google Scholar
|
|
31
|
Yu Z, Ye S, Hu G, Lv M, Tu Z, Zhou K and
Li Q: The RAF-MEK-ERK pathway: Targeting ERK to overcome obstacles
to effective cancer therapy. Future Med Chem. 7:269–289. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou C, Yang C and Chong D: E-cadherin
expression is associated with susceptibility and
clinicopathological characteristics of thyroid cancer: A
PRISMA-compliant meta-analysis. Medicine (Baltimore).
98:e161872019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kawai T, Iwata K, Shinotsuka Y, Kubo S,
Masuoka H, Yabuta T, Hirokawa M, Nakamura H, Miyauchi A and Komai
K: CD44v8-10 and CD44s are age-dependently expressed in primary
cultured papillary thyroid carcinoma cells and are associated with
cell proliferation. Kobe J Med Sci. 65:E1–E9. 2019.PubMed/NCBI
|
|
34
|
Hashimoto Y, Puddu F and Costanzo V:
RAD51- and MRE11-dependent reassembly of uncoupled CMG helicase
complex at collapsed replication forks. Nat Struct Mol Biol.
19:17–24. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Moiseeva T, Hood B, Schamus S, O'Connor
MJ, Conrads TP and Bakkenist CJ: ATR kinase inhibition induces
unscheduled origin firing through a Cdc7-dependent association
between GINS and And-1. Nat Commun. 8:13922017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chmielewski JP, Henderson L, Smith CM and
Christensen TW: Drosophila Psf2 has a role in chromosome
condensation. Chromosoma. 121:585–596. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pennati M, Cimino-Reale G, Gatti L and
Cassinelli G: Strategies to strike survival networks in cancer.
Crit Rev Oncog. 21:269–308. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Duan Z, Chen Q, Du L, Tong J, Xu S, Zeng
R, Ma Y, Chen X and Li M: Phagocytosis of Candida albicans
inhibits autophagic flux in macrophages. Oxid Med Cell Longev.
2018:49386492018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen H, Lin W, Lin P, Zheng M, Lai Y, Chen
M, Zhang Y, Chen J, Lin X, Lin L, et al: IL-10 produces a dual
effect on OGD-induced neuronal apoptosis of cultured cortical
neurons via the NF-κB pathway. Aging (Albany NY). 11:10796–10813.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Roberts PJ and Der CJ: Targeting the
Raf-MEK-ERK mitogen-activated protein kinase cascade for the
treatment of cancer. Oncogene. 26:3291–3310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang M, He S, Ma X, Ye Y, Wang G, Zhuang
J, Song Y and Xia W: GINS2 affects cell viability, cell apoptosis,
and cell cycle progression of pancreatic cancer cells via MAPK/ERK
pathway. J Cancer. 11:4662–4670. 2020. View Article : Google Scholar : PubMed/NCBI
|
